Societal preferences for adjuvant melanoma health states: UK and Australia
No studies have measured preference-based utility weights for specific toxicities and outcomes associated with approved and investigational adjuvant treatments for patients with resected high-risk melanoma.A cross-sectional study was conducted in the United Kingdom and Australia to obtain utilities...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
BioMed Central
2017
|